Efficacy of poly (ADP-ribose) polymerase inhibitors monotherapy and the impact to subsequent platinum-based chemotherapy in breast cancer susceptibility genes1/2-mutated ovarian cancer patients with secondary platinum-sensitive relapse

• Main Authors: Yana Ma (Author), Jiale Liu (Author), Ning Li (Author), Hualei Bu (Author), Yongwen Huang (Author), Chengjuan Jin (Author), Hao Wen (Author), Shuai Feng (Author), Hui Zhang (Author), Xiaorong Yang (Author), Beihua Kong (Author), Lingying Wu (Author), Kun Song (Author)
• Format: Book
• Published: BMC, 2023-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background The therapeutic effect of poly (ADP-ribose) polymerase inhibitors (PARPi) monotherapy compared with platinum-based chemotherapy, and the impact to subsequent platinum-based chemotherapy after PARPi resistance were inconclusive in breast cancer susceptibility genes (BRCA)1/2-mutat...